CH666184A5 - Composizione farmaceutica orale a base di ubichinoni. - Google Patents

Composizione farmaceutica orale a base di ubichinoni. Download PDF

Info

Publication number
CH666184A5
CH666184A5 CH3363/85A CH336385A CH666184A5 CH 666184 A5 CH666184 A5 CH 666184A5 CH 3363/85 A CH3363/85 A CH 3363/85A CH 336385 A CH336385 A CH 336385A CH 666184 A5 CH666184 A5 CH 666184A5
Authority
CH
Switzerland
Prior art keywords
yeast
pharmaceutical composition
coenzyme
coenzyme qio
composition according
Prior art date
Application number
CH3363/85A
Other languages
English (en)
Italian (it)
Inventor
Pierre-Noel Brasey
Original Assignee
Seuref Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref Ag filed Critical Seuref Ag
Priority to CH3363/85A priority Critical patent/CH666184A5/it
Priority to DE19863625459 priority patent/DE3625459A1/de
Priority to GB8618590A priority patent/GB2178662B/en
Priority to NL8601978A priority patent/NL8601978A/nl
Priority to IT8621395A priority patent/IT1213320B/it
Priority to BE2/61024A priority patent/BE905209A/nl
Priority to JP61184972A priority patent/JPS6259208A/ja
Priority to FR868611376A priority patent/FR2585953B1/fr
Publication of CH666184A5 publication Critical patent/CH666184A5/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH3363/85A 1985-08-06 1985-08-06 Composizione farmaceutica orale a base di ubichinoni. CH666184A5 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CH3363/85A CH666184A5 (it) 1985-08-06 1985-08-06 Composizione farmaceutica orale a base di ubichinoni.
DE19863625459 DE3625459A1 (de) 1985-08-06 1986-07-28 Ubichinon enthaltende pharmazeutische zusammensetzung fuer die orale verabreichung
GB8618590A GB2178662B (en) 1985-08-06 1986-07-30 Pharmacological composition having tissular metabolic activity
NL8601978A NL8601978A (nl) 1985-08-06 1986-08-01 Farmaceutisch preparaat bevattend ubichinon, voor orale toediening.
IT8621395A IT1213320B (it) 1985-08-06 1986-08-01 Composizione farmaceutica orale a base di ubichinoni.
BE2/61024A BE905209A (nl) 1985-08-06 1986-08-04 Farmaceutisch preparaat bevattend ubichinon,voor orale toediening.
JP61184972A JPS6259208A (ja) 1985-08-06 1986-08-05 ユビキノン含有医薬
FR868611376A FR2585953B1 (fr) 1985-08-06 1986-08-06 Composition pharmaceutique pour l'administration orale contenant de l'ubiquinone et procede

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3363/85A CH666184A5 (it) 1985-08-06 1985-08-06 Composizione farmaceutica orale a base di ubichinoni.

Publications (1)

Publication Number Publication Date
CH666184A5 true CH666184A5 (it) 1988-07-15

Family

ID=4254356

Family Applications (1)

Application Number Title Priority Date Filing Date
CH3363/85A CH666184A5 (it) 1985-08-06 1985-08-06 Composizione farmaceutica orale a base di ubichinoni.

Country Status (8)

Country Link
JP (1) JPS6259208A (ja)
BE (1) BE905209A (ja)
CH (1) CH666184A5 (ja)
DE (1) DE3625459A1 (ja)
FR (1) FR2585953B1 (ja)
GB (1) GB2178662B (ja)
IT (1) IT1213320B (ja)
NL (1) NL8601978A (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8703321D0 (sv) * 1987-08-27 1987-08-27 Sockerbolaget Ab Kostforsterkning
DE9402223U1 (de) * 1994-01-20 1994-04-14 Latta Bernd Flüssige Mixtur zur inneren Anwendung für den vorbeugenden Gesundheitsschutz
JP2005053923A (ja) * 2000-04-12 2005-03-03 Nisshin Pharma Inc 安定化されたユビデカレノン組成物およびユビデカレノン組成物の安定化方法
US6806069B2 (en) * 2001-01-09 2004-10-19 Pharmachem Laboratories, Inc. Ubiquinone composition and methods related thereto
US7708990B2 (en) 2004-03-23 2010-05-04 Kaneka Corporation Coenzyme Q compositions persisting in blood
TW200603786A (en) 2004-05-11 2006-02-01 Kaneka Corp Anti-fatigue composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5933354B2 (ja) * 1976-09-14 1984-08-15 鐘淵化学工業株式会社 補酵素ｑの製造法
EP0106309A3 (de) * 1982-10-12 1986-12-30 Kailash Kumar Dr. Prof. Gauri Biologisch aktive Extrakte, Verfahren zu deren Herstellung, sie enthaltende pharmazeutische und kosmetische Mittel und ihre Verwendung als Zusätze für Lebens- und Genussmittel
FR2536996B1 (fr) * 1982-12-01 1985-09-27 Grimberg Georges Association permettant d'ameliorer l'absorption de divers cations par l'organisme
CH654210A5 (it) * 1983-05-20 1986-02-14 Hasunor Ag Procedimento per ottenere preparati metabolicamente attivi ottenuti da lievito di qualsiasi tipo.

Also Published As

Publication number Publication date
BE905209A (nl) 1986-12-01
FR2585953B1 (fr) 1989-07-07
GB8618590D0 (en) 1986-09-10
DE3625459C2 (ja) 1992-03-26
FR2585953A1 (fr) 1987-02-13
DE3625459A1 (de) 1987-02-19
GB2178662A (en) 1987-02-18
IT1213320B (it) 1989-12-20
IT8621395A0 (it) 1986-08-01
JPS6259208A (ja) 1987-03-14
NL8601978A (nl) 1987-03-02
GB2178662B (en) 1989-09-06
JPH0380771B2 (ja) 1991-12-26

Similar Documents

Publication Publication Date Title
US4973467A (en) Dietary supplement for adults
US20080214492A1 (en) Folate based composition for treatment of the cardiovascular system
US20100021573A1 (en) Compositions and methods for the prevention of cardiovascular disease
AU2008258958B2 (en) Anti-fatigue Agents and Oral Compositions Containing Andrographolide as Active Ingredient
KR20020025088A (ko) 필수지방산 및 호모시스테인-저하제를 포함하는 약제학적및 영양학적 조성물
US20220000820A1 (en) Compositions and methods using at least one glycine or derivative thereof, at least one n-acetylcysteine or derivative thereof, and at least one nicotinamide riboside or nad+ precursor
US20200129463A1 (en) Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans
GB2596849A (en) Nutritional supplement composition for treating coronavirus infections, cancer, ME, post viral & Chronic fatigue syndrome & neurodegeneration in an individual
JP2002542191A (ja) グルタチオンの吸収を増しかつその効果を補強するのに有用な、カルニチンおよびグルタチオン含有組成物
EP2859896B1 (en) Pharmaceutical compositions for the treatment of muscular disorders
TWI359667B (en) Formulation for oral administration having a healt
US20120213757A1 (en) Nutritional supplement composition
EP1100507B1 (en) Use of a combination comprising a precursor of uric acid and antioxidant for the treatment of neurodegenerative deseases
CH666184A5 (it) Composizione farmaceutica orale a base di ubichinoni.
JPH07330593A (ja) 疲労改善剤
EP3043788B1 (en) D-glyceric acid or dl-glyceric acid for use in the treatment of degeneration diseases related to aging
CN101032562B (zh) 一种具有调节血压及保护心脑血管系统作用的保健品及其应用
JPWO2006104153A1 (ja) 血液中の抗酸化活性を高める組成物
EP1010429B1 (en) Pharmaceutical composition, in particular for dietetical use comprising a derivative of pyruvic acid and unripe bitter orange extract
JP4896531B2 (ja) 血中ＣｏＱ１０量を増加させる医薬組成物
RU2820163C2 (ru) Композиции и способы с использованием по меньшей мере одного глицина или его производного, по меньшей мере одного n-ацетилцистеина или его производного и по меньшей мере одного никотинамидрибозида или предшественника nad+
JPH04342528A (ja) アルコール代謝およびアセトアルデヒド代謝促進剤
Hemilä A re-evaluation of nutritional goals-not just deficiency counts
US20120157405A1 (en) Methods and Compositions for the Treatment of "Burning Feet Syndrome"
US20220362188A1 (en) Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans

Legal Events

Date Code Title Description
NV New agent

Representative=s name: E. BLUM & CO. PATENTANWAELTE

PUE Assignment

Owner name: SEUREF AG TRANSFER- F.W. WIRTZ & CO. GMBH

PL Patent ceased